Cargando…
Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article
PURPOSE: To provide an overview of altmetrics, including their potential benefits and limitations, how they may be obtained, and their role in assessing pharmacoepidemiologic research impact. METHODS: Our review was informed by compiling relevant literature identified through searching multiple heal...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004200/ https://www.ncbi.nlm.nih.gov/pubmed/29575351 http://dx.doi.org/10.1002/pds.4401 |
_version_ | 1783494685291970560 |
---|---|
author | Gamble, J.M. Traynor, Robyn L. Gruzd, Anatoliy Mai, Philip Dormuth, Colin R. Sketris, Ingrid S. |
author_facet | Gamble, J.M. Traynor, Robyn L. Gruzd, Anatoliy Mai, Philip Dormuth, Colin R. Sketris, Ingrid S. |
author_sort | Gamble, J.M. |
collection | PubMed |
description | PURPOSE: To provide an overview of altmetrics, including their potential benefits and limitations, how they may be obtained, and their role in assessing pharmacoepidemiologic research impact. METHODS: Our review was informed by compiling relevant literature identified through searching multiple health research databases (PubMed, Embase, and CIHNAHL) and grey literature sources (websites, blogs, and reports). We demonstrate how pharmacoepidemiologists, in particular, may use altmetrics to understand scholarly impact and knowledge translation by providing a case study of a drug‐safety study conducted by the Canadian Network of Observational Drug Effect Studies. RESULTS: A common approach to measuring research impact is the use of citation‐based metrics, such as an article's citation count or a journal's impact factor. “Alternative” metrics, or altmetrics, are increasingly supported as a complementary measure of research uptake in the age of social media. Altmetrics are nontraditional indicators that capture a diverse set of traceable, online research‐related artifacts including peer‐reviewed publications and other research outputs (software, datasets, blogs, videos, posters, policy documents, presentations, social media posts, wiki entries, etc). CONCLUSION: Compared with traditional citation‐based metrics, altmetrics take a more holistic view of research impact, attempting to capture the activity and engagement of both scholarly and nonscholarly communities. Despite the limited theoretical underpinnings, possible commercial influence, potential for gaming and manipulation, and numerous data quality‐related issues, altmetrics are promising as a supplement to more traditional citation‐based metrics because they can ingest and process a larger set of data points related to the flow and reach of scholarly communication from an expanded pool of stakeholders. Unlike citation‐based metrics, altmetrics are not inherently rooted in the research publication process, which includes peer review; it is unclear to what extent they should be used for research evaluation. |
format | Online Article Text |
id | pubmed-7004200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70042002020-02-13 Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article Gamble, J.M. Traynor, Robyn L. Gruzd, Anatoliy Mai, Philip Dormuth, Colin R. Sketris, Ingrid S. Pharmacoepidemiol Drug Saf Original Research PURPOSE: To provide an overview of altmetrics, including their potential benefits and limitations, how they may be obtained, and their role in assessing pharmacoepidemiologic research impact. METHODS: Our review was informed by compiling relevant literature identified through searching multiple health research databases (PubMed, Embase, and CIHNAHL) and grey literature sources (websites, blogs, and reports). We demonstrate how pharmacoepidemiologists, in particular, may use altmetrics to understand scholarly impact and knowledge translation by providing a case study of a drug‐safety study conducted by the Canadian Network of Observational Drug Effect Studies. RESULTS: A common approach to measuring research impact is the use of citation‐based metrics, such as an article's citation count or a journal's impact factor. “Alternative” metrics, or altmetrics, are increasingly supported as a complementary measure of research uptake in the age of social media. Altmetrics are nontraditional indicators that capture a diverse set of traceable, online research‐related artifacts including peer‐reviewed publications and other research outputs (software, datasets, blogs, videos, posters, policy documents, presentations, social media posts, wiki entries, etc). CONCLUSION: Compared with traditional citation‐based metrics, altmetrics take a more holistic view of research impact, attempting to capture the activity and engagement of both scholarly and nonscholarly communities. Despite the limited theoretical underpinnings, possible commercial influence, potential for gaming and manipulation, and numerous data quality‐related issues, altmetrics are promising as a supplement to more traditional citation‐based metrics because they can ingest and process a larger set of data points related to the flow and reach of scholarly communication from an expanded pool of stakeholders. Unlike citation‐based metrics, altmetrics are not inherently rooted in the research publication process, which includes peer review; it is unclear to what extent they should be used for research evaluation. John Wiley and Sons Inc. 2018-03-24 2020-01 /pmc/articles/PMC7004200/ /pubmed/29575351 http://dx.doi.org/10.1002/pds.4401 Text en © 2018 The Authors. Pharmacoepidemiology and Drug Safety. Published by John Wiley & Sons, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Gamble, J.M. Traynor, Robyn L. Gruzd, Anatoliy Mai, Philip Dormuth, Colin R. Sketris, Ingrid S. Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article |
title | Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article |
title_full | Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article |
title_fullStr | Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article |
title_full_unstemmed | Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article |
title_short | Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article |
title_sort | measuring the impact of pharmacoepidemiologic research using altmetrics: a case study of a cnodes drug‐safety article |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004200/ https://www.ncbi.nlm.nih.gov/pubmed/29575351 http://dx.doi.org/10.1002/pds.4401 |
work_keys_str_mv | AT gamblejm measuringtheimpactofpharmacoepidemiologicresearchusingaltmetricsacasestudyofacnodesdrugsafetyarticle AT traynorrobynl measuringtheimpactofpharmacoepidemiologicresearchusingaltmetricsacasestudyofacnodesdrugsafetyarticle AT gruzdanatoliy measuringtheimpactofpharmacoepidemiologicresearchusingaltmetricsacasestudyofacnodesdrugsafetyarticle AT maiphilip measuringtheimpactofpharmacoepidemiologicresearchusingaltmetricsacasestudyofacnodesdrugsafetyarticle AT dormuthcolinr measuringtheimpactofpharmacoepidemiologicresearchusingaltmetricsacasestudyofacnodesdrugsafetyarticle AT sketrisingrids measuringtheimpactofpharmacoepidemiologicresearchusingaltmetricsacasestudyofacnodesdrugsafetyarticle |